Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo.

Diabetes Res Clin Pract

Division of Diabetes, Clinical Nutrition and Endocrinology, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan; Division of Metabolism and Clinical Nutrition, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan. Electronic address:

Published: October 2013

We examined GLP-1 secretion from the pancreas of a patient with glucagonoma and pancreatic resection by measuring GLP-1 after meal ingestion or selective arterial calcium injection, and immunohistochemical analysis. Our findings support the notion that GLP-1 is secreted from pancreatic α cells in humans.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2013.08.005DOI Listing

Publication Analysis

Top Keywords

glucagon-like peptide-1
8
peptide-1 secretion
8
patient glucagonoma
8
pancreatic cells
8
enhanced glucagon-like
4
secretion patient
4
glucagonoma implications
4
implications glucagon-like
4
secretion pancreatic
4
cells vivo
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!